Comparison

Eribulin mesylate European Partner

Item no. TMO-T13687-25mg
Manufacturer TargetMol
CASRN 441045-17-6
Amount 25 mg
Quantity options 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles CS(O)(=O)=O.[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias ER-086526 mesylate,E7389 mesylate,B1939 mesylate
Shipping Condition Cool pack
Available
Manufacturer - Targets
Microtubule Associated|||Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
826
Description
Eribulin mesylate (E7389 mesylate) (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer.
Pathways
Cytoskeletal Signaling|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close